Pharma bigwig AstraZeneca Pharma India has appointed Bhavana Agrawal as the new Chief Finance Officer (CFO). A company statement mentioned that her appointment will come into effect from October 1, 2023, following a transition period.
Bhavana succeeds Rajesh Marwaha, who will step down as CFO and full-time director of the company on September 30, 2023. Rajesh has been key in developing strategic frameworks for AstraZeneca Pharma. He has also been a strong anchor as a board member and has been behind important initiatives aimed at improving access to healthcare.
"With his extensive and diverse experience across industries, Rajesh has been a valuable asset and guiding light for us." I'd like to thank him for his outstanding leadership and significant contribution to our country's legacy. At the same time, I am delighted to welcome Bhavana at this critical point in our journey of growth through innovation. We are constantly pushing the boundaries of science to deliver life-changing medicines, and I am confident that with her unique global experience, we will be able to accelerate our goal of transforming patient outcomes," said Dr. Sanjeev Panchal, country President, AstraZeneca India.
Bhavana's previous role saw her as the CFO of the services business at GE Healthcare for Middle East, Africa & Russia. In her role at GE Healthcare, she was responsible for revenue, costs, cash, planning session and financial closing activities in more than 30 countries. In her new role, Bhavana will be responsible for the company's financial strategy and operations, planning and analysis, and investor relations.
